Pfizer's rejig made for growth, but it's also handy for a future split: executives
admin 31st July 2018 Uncategorised 0Pfizer’s new three-unit structure may be all about driving growth for now. But don’t count out a long-awaited generics divestment down the line. That’s the message executives had for investors Tuesday as they clarified the reasoning behind Pfizer’s latest reorganization.
More: Pfizer's rejig made for growth, but it's also handy for a future split: executives
Source: fierce